Burrill’s Indiana Life Sciences Forum scheduled for Oct. 22 and 23
INDIANAPOLIS, IN, September 17, 2007 – The biotechnology and pharmaceutical industries are at a crossroads. Both industries are turning to new partners and contract service providers out of a rising need to share risks, reduce costs and improve productivity in the pursuit of new drug therapies that often take more than $1 billion to bring to market. Indiana’s life sciences companies can be a solution to the challenges of this new business model.
The third annual Burrill Life Sciences Media Group/BioCrossroads Indiana Life Sciences Forum will address these issues as well as highlight Indiana’s progress in the life sciences and how Indiana’s existing and emerging companies are playing on an expanding national biotechnology stage.
Local and national speakers will present on topics such as Drug Discovery, Definition, Development and Delivery, Indiana’s Progress as a BioPharma Development Center, and Virtually-Integrated Pharmaceutical Companies in Action.
Darren Carroll, Senior Managing Director, Lilly Ventures
Lynn Kippenhan, Global Vice President Sales, Marketing, and Commercial Development, Covance Central Laboratory Services
Duane Roth, CEO, San Diego’s CONNECT
James White, President & CEO, CoLucid Pharmaceuticals, Inc.
“Indiana is matching its rich life science asset base with a growing entrepreneurial culture. Important research and innovation is occurring there which is driving more venture funding – they are definitely making their mark in the industry,” said G. Steven Burrill, CEO Burrill & Company, a leading national venture capital firm and participating investor in the BioCrossroads-sponsored Indiana Future Fund. Burrill will give his annual Life Sciences State of the Union/A Global View presentation at the conference.
“There’s no question that Indiana is a major player in the life sciences, both in discovering new drugs and devices and then developing and manufacturing them for the global healthcare marketplace,” said David Johnson, President and CEO of BioCrossroads. Highlighting the companies that are uniquely positioned to support both large pharma organizations and the smaller biotech companies, Johnson will lead a panel discussion on the development and delivery of biotech/pharmaceutical products.
Indianapolis is the only city between the East and West coasts to host a Burrill Life Sciences Media Group event this year. Approximately 250 life sciences thought leaders, CEOs, venture capitalists and bankers are expected to attend the conference which will be at the Westin Indianapolis. The kick-off reception is on Monday, Oct. 22 6:00-8:00 p.m. and the conference will begin at 8:30 a.m. on Tuesday, Oct. 23.
In 2006, Indiana was identified as one of the nation’s top four life sciences leaders as defined by the number and concentration of life sciences-related job, according to the report, “Growing the Nation’s Bioscience Sector: State Bioscience Initiatives 2006”. A follow-up report, issued earlier this year, identified the Indianapolis Metropolitan Statistical Area (MSA) as home to 24,051 bioscience jobs, ranking ninth in the nation.
For more information on the Indiana Life Sciences Forum and to register please visit:
About Burrill Life Sciences Media Group
Burrill Life Sciences Media Group, a joint venture of Burrill & Company and Nielsen Business Media, produces worldwide life sciences conferences, Biotech-2007, bio-intelligence reports, and The Journal of Life Sciences, with the California Health Institute. Biotech-2007, an annual book on the “State of the Industry”, has been an important part of the biotech industry’s view of itself over the last 20 years.
BioCrossroads (www.biocrossroads.com) is Indiana’s initiative to help grow the life sciences, a public-private collaboration that supports the region’s research and corporate strengths while encouraging new business development. BioCrossroads provides money and support to life sciences businesses, launches new life sciences businesses, expands collaboration and partnerships among Indiana’s life science institutions, expands science education and markets Indiana’s life sciences industry.
# # #